These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29384366)

  • 1. Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects.
    Jones NG; Catta-Preta CMC; Lima APCA; Mottram JC
    ACS Infect Dis; 2018 Apr; 4(4):467-477. PubMed ID: 29384366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.
    Osorio-Méndez JF; Cevallos AM
    Front Cell Infect Microbiol; 2018; 8():439. PubMed ID: 30666299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Reveals Their Role in Flagellar Attachment.
    Lander N; Li ZH; Niyogi S; Docampo R
    mBio; 2015 Jul; 6(4):e01012. PubMed ID: 26199333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.
    Vermelho AB; Capaci GR; Rodrigues IA; Cardoso VS; Mazotto AM; Supuran CT
    Bioorg Med Chem; 2017 Mar; 25(5):1543-1555. PubMed ID: 28161253
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Trevisan RO; Santos MM; Desidério CS; Alves LG; de Jesus Sousa T; de Castro Oliveira L; Jaiswal AK; Tiwari S; Bovi WG; de Oliveira-Silva M; Costa-Madeira JC; Castellano LRC; Silva MV; Azevedo V; Rodrigues Junior V; Oliveira CJF; de Castro Soares S
    Dis Markers; 2020; 2020():9130719. PubMed ID: 33488847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics. Leishmania exploit sex.
    Miles MA; Yeo M; Mauricio IL
    Science; 2009 Apr; 324(5924):187-9. PubMed ID: 19359570
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease.
    de Almeida Nogueira NP; Morgado-Díaz JA; Menna-Barreto RF; Paes MC; da Silva-López RE
    Acta Trop; 2013 Oct; 128(1):27-35. PubMed ID: 23770204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
    Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens.
    Kelly P; Hadi-Nezhad F; Liu DY; Lawrence TJ; Linington RG; Ibba M; Ardell DH
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007983. PubMed ID: 32106219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids.
    Lander N; Chiurillo MA
    J Eukaryot Microbiol; 2019 Nov; 66(6):981-991. PubMed ID: 31211904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides isolated from Phyllomedusa nordestina (Amphibia) alter the permeability of plasma membrane of Leishmania and Trypanosoma cruzi.
    Pinto EG; Pimenta DC; Antoniazzi MM; Jared C; Tempone AG
    Exp Parasitol; 2013 Dec; 135(4):655-60. PubMed ID: 24113627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear DNA replication and repair in parasites of the genus Leishmania: Exploiting differences to develop innovative therapeutic approaches.
    Uzcanga G; Lara E; Gutiérrez F; Beaty D; Beske T; Teran R; Navarro JC; Pasero P; Benítez W; Poveda A
    Crit Rev Microbiol; 2017 Mar; 43(2):156-177. PubMed ID: 27960617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High throughput screening for anti-Trypanosoma cruzi drug discovery.
    Alonso-Padilla J; Rodríguez A
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors in potential drug development for Leishmaniasis.
    Das P; Alam MN; Paik D; Karmakar K; De T; Chakraborti T
    Indian J Biochem Biophys; 2013 Oct; 50(5):363-76. PubMed ID: 24772958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protozoan persister-like cells and drug treatment failure.
    Barrett MP; Kyle DE; Sibley LD; Radke JB; Tarleton RL
    Nat Rev Microbiol; 2019 Oct; 17(10):607-620. PubMed ID: 31444481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.